Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 14.39M
March 31, 2026 14.93M
December 31, 2025 11.16M
September 30, 2025 14.15M
June 30, 2025 15.30M
March 31, 2025 14.87M
December 31, 2024 17.12M
September 30, 2024 19.03M
June 30, 2024 15.25M
March 31, 2024 15.44M
December 31, 2023 17.47M
September 30, 2023 18.94M
June 30, 2023 21.41M
March 31, 2023 29.48M
December 31, 2022 38.41M
September 30, 2022 43.58M
June 30, 2022 51.17M
Date Value
March 31, 2022 55.71M
December 31, 2021 62.96M
September 30, 2021 68.67M
June 30, 2021 68.35M
March 31, 2021 76.44M
December 31, 2020 41.97M
September 30, 2020 42.08M
June 30, 2020 38.19M
March 31, 2020 34.94M
December 31, 2019 43.22M
September 30, 2019 52.97M
June 30, 2019 54.71M
March 31, 2019 38.18M
December 31, 2018 38.64M
September 30, 2018 51.51M
June 30, 2018 40.14M
March 31, 2018 11.89M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Numinus Wellness, Inc. 1.852M
Cocrystal Pharma, Inc. 4.649M
Edesa Biotech, Inc. 12.72M
CNBX Pharmaceuticals, Inc. 0.0128M
Invion Ltd. --

Total Assets (Quarterly) Related Metrics